 |
|
|
| |
Efficacy and Safety of a Twice-Yearly Regimen
of Lenacapavir, Teropavimab, and Zinlirvimab: Phase 2 Week 52 Results
|
| |
| |
EACS 2025, The 20th European AIDS Conference, Paris, France, 15-18 October 2025
Onyema Ogbuagu1*, James McMahon2, Aditya Gaur3, Susan J. Little4, Edwin DeJesus5, Princy Kumar6, David Wheeler7, Helmut Albrecht8, Anson Wurapa9, Hui Liu10, Nan Zhang10, Kwad Mponponsuo10, Sean E. Collins10, Joseph Eron11
|
| |
|
|
|
|
|
